title: Janus-activated kinase 2 inhibitors: a new era of targeted therapies providing significant clinical benefit for Philadelphia chromosome-negative myeloproliferative neoplasms.
authors.forename: Srdan
authors.initials: S
authors.lastname: Verstovsek
mesh_terms: D005260:Female; D005544:Forecasting; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors* / Q000235:genetics; D008297:Male; D058990:Molecular Targeted Therapy / Q000379:methods*; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000235:genetics; D010677:Philadelphia Chromosome / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D047428:Protein Kinase Inhibitors; D053614:Janus Kinase 2